Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · IEX Real-Time Price · USD
2.570
-0.080 (-3.02%)
At close: Apr 24, 2024, 4:00 PM
2.550
-0.020 (-0.78%)
After-hours: Apr 24, 2024, 5:52 PM EDT
Company Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada.
The company was founded in 2016 and is based in Littleton, Colorado.
Vivos Therapeutics, Inc.
| Country | United States |
| IPO Date | Dec 11, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 114 |
| CEO | R. Kirk Huntsman |
Contact Details
Address: 7921 Southpark Plaza, Suite 210 Littleton, Colorado 80120 United States | |
| Phone | (866)908-4867 |
| Website | vivos.com |
Stock Details
| Ticker Symbol | VVOS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $6.00 |
| CIK Code | 0001716166 |
| CUSIP Number | 92859E108 |
| ISIN Number | US92859E2072 |
| Employer ID | 81-3224056 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| R. Kirk Huntsman | Co-Founder, Chairman of the Board and Chief Executive Officer |
| Bradford K. Amman | Chief Financial Officer, Treasurer and Secretary |
| Todd Huntsman | Co-Founder and Senior Vice President of Product and Technology |
| RaeAnn Byrnes | Co-Founder and Senior Vice President of Events and Clinical Advisory Services |
| Susan McCullough | Co-Founder and Executive Vice President of Operations |
| Julie Gannon | Senior Vice President of Strategic Sales and Marketing and Investor Relations Officer |
| Nicholas M. DeGennaro | Senior Vice President of Medical Integration Division |
| Ruth Hembree | Senior Vice President of Practice Services |
| Stephanie Huebner | Senior Vice President of Dental Service Integration |
| John Ballard | Senior Vice President of Technology |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 22, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Apr 9, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Mar 29, 2024 | 8-K | Current Report |
| Mar 28, 2024 | 10-K | Annual Report |
| Feb 15, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Dec 1, 2023 | EFFECT | Notice of Effectiveness |
| Dec 1, 2023 | 424B1 | Filing |
| Nov 30, 2023 | 8-K | Current Report |